| Literature DB >> 29066369 |
Shuxuan Huang1, Huichun Tong2, Ming Lei3, Miaomiao Zhou1, Wenyuan Guo1, Guihua Li1, Xiaolu Tang1, Zhe Li1, Mingshu Mo1, Xiuping Zhang4, Xiang Chen1, Luan Cen1, Lei Wei5, Yousheng Xiao1, Kaiping Li6, Qinghui Huang7, Xinling Yang8, Weiguo Liu9, Li Zhang9, Shaogang Qu10, Shaomin Li11, Pingyi Xu12.
Abstract
In Alzheimer's disease (AD), dementia severity correlates most strongly with decreased synapse density in the hippocampus and cerebral cortex. Although studies in rodents have established that hippocampal long-term potentiation (LTP) is inhibited by soluble oligomers of beta-amyloid (Aβ), the synaptic mechanisms remain unclear. Here, field excitatory postsynaptic potentials (fEPSP) recordings were made in the CA1 region of mouse hippocampal slices. The medium of APP-expressing CHO cells, which contain soluble forms of Aβ including small oligomers, inhibited LTP and facilitated long-term depression (LTD), thus making the LTP/LTD curve shift toward the right. This phenomenon could be mimicked by the non-selective glutamate transporter inhibitor, DL-TBOA. More specifically, the Aβ impaired LTP and facilitated LTD were occluded by the selective astrocytic glutamate transporter inhibitors, TFB-TBOA. In cultured astrocytes, the Aβ oligomers also decrease astrocytic glutamate transporters (EAAT1, EAAT2) expression. We conclude that soluble Aβ oligomers decrease the activation of astrocytic glutamate transporters, thereby impairing synaptic plasticity.Entities:
Keywords: Alzheimer’s disease; Astrocytes; Glutamate transporters; Long-term potentiation; Synaptic plasticity; TBOA
Mesh:
Substances:
Year: 2017 PMID: 29066369 DOI: 10.1016/j.brainres.2017.10.011
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252